Gene signature for cancer stem cells may provide drug targets

A subset of tumor cells that remain after a woman with breast cancer undergoes treatment with either anti-cancer or anti-hormone therapy shows a "gene signature" that could be used to define targets for developing new drugs against the disease, said a consortium of researchers led by Baylor College of Medicine. The report appears in the current issue of the Proceedings of the National Academy of Sciences.

Read the whole article on Physorg

More from Physorg